138 related articles for article (PubMed ID: 35946556)
1. GATA3 positively regulates PAR1 to facilitate in vitro disease progression and decrease cisplatin sensitivity in neuroblastoma via inhibiting the hippo pathway.
Wang J; Dai W; Zhang M
Anticancer Drugs; 2023 Jan; 34(1):57-72. PubMed ID: 35946556
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
[TBL] [Abstract][Full Text] [Related]
3. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells.
Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ
Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291
[TBL] [Abstract][Full Text] [Related]
4. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway.
Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM
Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656
[TBL] [Abstract][Full Text] [Related]
6. Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein/Hippo signaling pathway.
Li T; Li Y
Immunobiology; 2023 Mar; 228(2):152324. PubMed ID: 36608594
[TBL] [Abstract][Full Text] [Related]
7. Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.
Kling MJ; Griggs CN; McIntyre EM; Alexander G; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
BMC Cancer; 2021 Sep; 21(1):1061. PubMed ID: 34565342
[TBL] [Abstract][Full Text] [Related]
8. LncRNA FAM83A-AS1 promotes epithelial-mesenchymal transition of pancreatic cancer cells via Hippo pathway.
Wang H; Ding Y; Zhu Q; Yu Z; Wang Q; Gong A; Xu M
Cell Cycle; 2023 Jun; 22(12):1514-1527. PubMed ID: 37245082
[TBL] [Abstract][Full Text] [Related]
9. SNHG16 Silencing Inhibits Neuroblastoma Progression by Downregulating HOXA7 via Sponging miR-128-3p.
Bao J; Zhang S; Meng Q; Qin T
Neurochem Res; 2020 Apr; 45(4):825-836. PubMed ID: 31919621
[TBL] [Abstract][Full Text] [Related]
10. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer.
Chen M; Zhang H; Shi Z; Li Y; Zhang X; Gao Z; Zhou L; Ma J; Xu Q; Guan J; Cheng Y; Jiao S; Zhou Z
J Biol Chem; 2018 Sep; 293(37):14455-14469. PubMed ID: 30072378
[TBL] [Abstract][Full Text] [Related]
11. Circ-CUX1 Accelerates the Progression of Neuroblastoma via miR-16-5p/DMRT2 Axis.
Zhang X; Zhang J; Liu Q; Zhao Y; Zhang W; Yang H
Neurochem Res; 2020 Dec; 45(12):2840-2855. PubMed ID: 33000435
[TBL] [Abstract][Full Text] [Related]
12. Tetrandrine induces apoptosis in human neuroblastoma through regulating the Hippo/YAP signaling pathway.
Zhao Q; Jia X; Zhang Y; Dong Y; Lei Y; Tan X; Williamson RA; Wang A; Zhang D; Ma J
Biochem Biophys Res Commun; 2019 Jun; 513(4):846-851. PubMed ID: 31003773
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol inhibits TGF-β1-induced EMT in gastric cancer cells through Hippo-YAP signaling pathway.
Deng L; Zou J; Su Y; Wang M; Zhao L
Clin Transl Oncol; 2022 Nov; 24(11):2210-2221. PubMed ID: 35842894
[TBL] [Abstract][Full Text] [Related]
14. HMGA2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway.
Xu J; Fang X; Long L; Wang S; Qian S; Lyu J
Cancer Biol Ther; 2021 Jan; 22(1):5-11. PubMed ID: 33307962
[TBL] [Abstract][Full Text] [Related]
15. YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma.
Yang C; Tan J; Zhu J; Wang S; Wei G
Oncotarget; 2017 Jun; 8(23):37154-37163. PubMed ID: 28415761
[TBL] [Abstract][Full Text] [Related]
16. E2F1 induced neuroblastoma cell migration and invasion via activation of CENPE/FOXM1 signaling pathway.
Wang J; Dai W; Zhang M
Int J Neurosci; 2024 May; 134(5):530-542. PubMed ID: 36168932
[No Abstract] [Full Text] [Related]
17. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
[TBL] [Abstract][Full Text] [Related]
18. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].
Yan R; Liang ZW; Liu HS; Ge Y; An GY
Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016
[No Abstract] [Full Text] [Related]
19. Human cytomegalovirus inhibits the proliferation and invasion of extravillous cytotrophoblasts via Hippo-YAP pathway.
Kong Q; Li J; Zhao L; Shi P; Liu X; Bian C; Liu J; Liu T
Virol J; 2021 Oct; 18(1):214. PubMed ID: 34717661
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA DLX6-AS1 promotes neuroblastoma progression by regulating miR-107/BDNF pathway.
Zhang HY; Xing MQ; Guo J; Zhao JC; Chen X; Jiang Z; Zhang H; Dong Q
Cancer Cell Int; 2019; 19():313. PubMed ID: 31787850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
